Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Tribunal rejects pharma firms plea seeking to review order to recover Rs 1.55 crore penalty

Ruchika Sharma15 July 2021 1:28 PM IST

New Delhi: The National Green Tribunal Tuesday refused to entertain a plea seeking to review its order directing the Telangana Pollution Control Board...

Caplin Steriles Sumatriptan injection gets USFDA okay for treating migraine, cluster headache

Ruchika Sharma15 July 2021 11:00 AM IST

Chennai: Caplin Steriles Limited, a subsidiary company of Caplin Point Laboratories Limited, has been granted final approval from the United States...

Apex Labs oral antiviral CleVira tablets approved as supporting measure for mild to moderate Covid-19

Ruchika Sharma15 July 2021 10:30 AM IST

New Delhi: Apex Laboratories Private Limited has recently announced the approvaI of antiviral drug CleVira as a supporting measure for Mild to...

Sputnik V single dose triggers strong antibody response, claims study

Ruchika Sharma15 July 2021 10:00 AM IST

New Delhi: A single dose of the Sputnik V vaccine may be enough to elicit strong antibody response against SARS-CoV-2, the virus that causes COVID-19,...

USFDA warns against JnJ COVID vaccine for neurological disorder

Ruchika Sharma14 July 2021 1:32 PM IST

GBS is a rare neurological condition in which the body's immune system attacks the protective coating on nerve fibers.

Lupin launches generic equivalent of Kerydin Topical Solution in US

Ruchika Sharma14 July 2021 11:30 AM IST

Mumbai: Global pharma major, Lupin Limited, has announced the US launch of Tavaborole Topical Solution, 5% having received an approval from the United...

Serum Institute to begin Sputnik V production in September

Ruchika Sharma14 July 2021 11:00 AM IST

New Delhi: Serum Institute of India (SII) will start production of Sputnik vaccine at the company''s facilities in September, Russian Direct...

RDIF expects to release Sputnik V, AstraZeneca mix, match COVID vaccine results by July end

Ruchika Sharma14 July 2021 10:30 AM IST

New Delhi: Russian Direct Investment Fund (RDIF) is expecting to release the results of Sputnik V and Astra-Zeneca 'mix and match' vaccine by the end...

Govt exempts customs duty on import of raw materials for Covid test kits, APIs for Amphotericin B

Ruchika Sharma14 July 2021 10:15 AM IST

New Delhi: The government has exempted basic customs duty on imports of specified API/ excipients for Amphotericin B and raw materials for...

Covid-19: FDC launches first Favipiravir Oral Suspension Favenza in India

Ruchika Sharma13 July 2021 12:35 PM IST

Mumbai: Home-grown pharma major, FDC Limited, has announced the launch of India's first oral suspension of Favipiravir - Favenza Oral Suspension,...

Dr Reddys says Sputnik V 2nd dose shortage to delay India's full rollout

Ruchika Sharma13 July 2021 11:30 AM IST

New Delhi: India's full rollout of the Sputnik V COVID-19 vaccine will have to be put on hold until the Russian producer provides equal quantities of...

Bharat Biotech submits documents for Covaxin emergency use listing to WHO

Ruchika Sharma13 July 2021 9:45 AM IST

New Delhi: Bharat Biotech on Monday said it has submitted all documents required for the emergency use listing (EUL) of its COVID-19 vaccine Covaxin...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok